Summary. Several partially purified preparations of NSILN-S were tested for sulfation activity on rat and chicken embryo cartilage. A eleareut stimulation was obtained with as little as 0.1 fzU/ml and a near maximal effect with 10 ~xU/ml. In no instance could sulfation activity be dissociated from NSILA-S. It is, therefore, likely that NSILA-S and sulfation activity are exerted by one and the same molecule. It is, however, compatible with our results and those from other laboratories that still other substances with sulfation activity besides NSILA-S may be present in serum. Morell's findings [7, 8] according to which NSILA-S stimulates growth and metabolism of chicken embryo fibroblasts and our results on NSIL/k-S stimulation of sulfate incorporation into cartilage point to a possible physiological role of NSILA-S as a growth factor.
In 1959 several groups of investigators observed that only a small portion of total insulin-like activity of serum was inhibited by guinea pig anti-insulin serum. This activity of serum was termed nonsuppressible insulin-like activity (NSILA) [1] . Later it was shown that NSILA consists of at least 2 components [2] . 1) NSILA-P (precipitated by acid-ethanol), amounting to approximately 80% of total NSILA, with a molecular weight of approximately 100000 and 2) NSILA-S (soluble in acid-ethanol), amounting to approximately 20% of total NSILA, with a molecular weight of 7 500. NSILA-S is a small, one chain peptide with 2 or 3 disulfide bridges. Hnmbel et al. [3] have purified this molecule from serum and have determined its aminoacid composition which shows no similarity to that of insulin or proinsulin. NSILA-S and crystalline insulin are very similar with regard to their qualitative effects on adipose tissue and muscle in vitro. NSILA-S is approximately 50 times less active, mole per mole, than insulin [4] . Lately, several eleareut differences have been observed between these two substances. First, NSILA-S is barely inactivated by the perfused rat liver [4] . Second, NSILA-S has a prolonged blood sugar lowering activity after i.v. administration in adrenMeetomized rats and stimulates glucose incorporation into glycogen of muscle of diabetic rats for much longer than insulin [4, 5, 6] . Third and most importantly, NSILA-S is approximately 20 times more active than insulin in stimulating thymidine incorporation into DNA and cell replication of fibroblasts in culture [7, 8] . Because of this growth promoting effect of NSILA-S on undifferentiated cells we were interested to investigate the influence of NSILA-S on more differentiated cells. The studies were also motivated by the finding that partially purified preparations of sulfation factor * This work was supported by a grant (3.85.69) from the Sehweizerische Nationalfonds.
exerted nonsuppressible insulin-like activity [9, 10] . The so called sulfaetion factor of serum stimulates sulfate incorporation into ehondroitin sulfate of cartilage and thymidine incorporation into DNA [11] . Therefore, the sulfation assay was set up to find out whether or not NSILA-S has any activity and if so, whether the sulfation factor might indeed be the same substance as NSILA-S, as proposed earlier [9, 10] . Furthermore, the effects of NSILA-S were compared with those of insulin, which has been demonstrated to be a "sulfation factor" in pharmacological concentrations [12] .
Material and Methods
Sulfate incorporation into cartilage of rats was assayed by the technique of Yde [13] . Instead of hypophysectomized animals we used female OsborneMendel rats after three days of fasting, with an initial weight of 60 g. They had free access to water eontMning vitamin K in order to prevent bleeding. Weight loss after 3 days of fasting averaged 30~o. The two lowest ribs were used [13] . Segments of cartilage were prepared from the middle portion of the ribs, at least 2 mm removed from the costoehondrM junction and 5 mm from the sternum. The ribs were cut into pieces of 2 mm length (dry weight between 0.4 and 0.8 mg). In this manner 14 segments of cartilage were obtained per rat. Krebs phosphate buffer was used as an incubation medium [14] . To each 100 ml of medium was added 1 mg of phenol red as pI-Lindicator and 200 mg of human serum albumin, the latter to keep insulin and NSILA-S in solution and to prevent their adsorption to glass.
The day before the experiment the active growth promoting substances were added to the medium, pipetted into the vials and kept frozen. The following morning 4 rats were decapitated, the ribs were dissected on a sterile workbench, the segments prepared and immediately added to the medium. Segments from the same animal were distributed at random among the samples to be assayed. The ineubation was carried out in a Dubnoff shaking incubator at 37 ~ C and 60 r.p.m. After 6 h of preineubation, 100 ~1 of medium containing 1 ~Ci of 3aS was added. 24 h later, cultures of the incubation medium were made to detect eventuaI bacterial contamination, the pI-I was determined and the vials were put in boiling water for 5 rain to terminate the reaction. Each segment was put into a hole of an agglutination plate, the plate covered with gauze and put under running tap water for 12 h. The segments were air-dried for 20 h, weighed on a microbalance, with an accuracy of -4-5 y.g, put in scintillation vials with 90~o formic acid and boiled in a water bath for 40 min with constant shaking. 5 ml of a scintillation cocktail (Instagel) was added and asS was counted. The results were expressed in epm/mg dry weight of cartilage. In a few instances cartilage from chicken embryos was used aec0rding to the technique of Hall [15] . The conditions were the same as those chosen for rat cartilage except for a preineubation time of 2 h and an incubation time of 6 h.
Three different preparations of NSILA-S were obtained from Dr. R.E. gumbel (Institute of Biochemistry, University of Zurich). The large scale purification procedure of NSILA-S starts with an acetone powder of Cohn fraction B of human plasma, subsequent acid alcohol extraction and purification on Sephadex G-75 in 1 M acetic acid, according to methods previously described [3, 6] . Serum of a healthy 24 year old man and of 2 patients with active acromegaly were used as standard sera. For statistical analysis Student's T-test was applied. The specific activity of the NSILA-S preparations was determined in the rat epididymal adipose tissue assay standardized with crystalline pork insulin [1] .
Results
As may be seen from Fig. 1 , three preparations of NSILA-S with specific activities from 0.8 to 61.0 mU/mg stimulate the incorporation of ass into rat cartilage. In the steep ascending part of the curve, between 0.1 and 10 tzU/ml, all three curves are similar although by no means parallel. Almost maximal effects are obtained with as little as 10 ~U of NSILA-S/ml. The preparation with the lowest specific activity (0.8 mU/mg) is inhibitory at higher concentrations. Fig. 2 A shows that the effects of maximal concentrations of insulin and NSILA-S on asS-incorporation into rat cartilage are similar. However, NSILA-S is active in the microunit range, insulin only in the millinnit range. It appears from these curves that NSILA-S is 100 to 1 000 times more active than insulin compared to the respective activities on adipose tissue.
As shown in Fig. 2 B, 10~o serum of an acromegalie patient stimulates as-S-incorporation to a maximum of 250% above base line. This value is not quite significantly higher than that obtained with 500 ~U of NSILA-S/ml (0.10 > p > 0.05) and significantly higher (0.02 > p > 0.01) than that obtained with 10 tzU/ml of NSILA-S. ttowever, the curve obtained with serum has another shape and is steeper than that with NSILA-S or insulin. 10~ serum of a normal subject stimulates asS incorporation to 179~o above base line which is equivalent to the effect of approximately 2 ~U/ml of NSILA-S. These data are in good agreement with the finding of gakob et al. [2] 
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Diabetologia the results presented in Fig. 2 A. The results presented in Table 1 show that NSILA-S also stimulates cartilage of chicken embryos. Crystalline insulin in a concentration of 100 mU/ml and 10~o serum of a patient with acromcgaly have a somewhat greater effect in this assay system than 5 ~U of NSILA-S/ml. Incorporation of 3~S into chicken embryo cartilage in % above basal incorporation under stimulation with Basal NSILA-S, 5 fzU/ml Crystalline insulin 10% serum of patient (0.8 mU/mg dry weight) 100 mUlml with aeromegaly 100% ::]= 3.2% 168% * =J= 1.5.2% 192% * • 11.8% 179% * • 9.8% (n = 27) (n = 8) (n = 8) (n = 4)
Discussion
The sulfation assay with rat cartilage is time consuming and relatively inaccurate. We preferred this assay to the chicken assay because maximal stimulation is greater. Our main findings may be expressed in the following manner: NSILA-S purified on a large scale from human serum stimulates the incorporation of ~S into both rat and chicken cartilage. Stimulation of rat and chicken cartilage occurs at concentrations of purified NSILA-S in which this peptide seems to be present in serum under physiological conditions. 10% serum of an aeromegalic patient was slightly more active than maximal concentrations of purified NSILA-S in the rat cartilage assay, but not in the chicken assay. The ascending part of the purified NSILA-S on rat cartilage are different since the dose response curves are not the same. We have no explanation why 35S-incorporation tended to show a plateau at 50% above the baseline at concentrations of NSILA-S between 0.01 and 1 ~U/ml.
Our results support tIall's suggestion [9] that NSILA-S and the sulfation factor may be biological activities of one and the same molecule in serum. Since the incorporation of 85S into cartilage was stimulated to a greater extent by maximal concentrations of acromegalic serum than by maximal coneentrations of NSILA-S and since the dose response curves have entirely different slopes, it is likely that still other substances in serum have sulfation activity or else that NSILA-S is altered during the extraction procedure.
The following two major findings support the hypothesis that NSILA-S and one of the principle molecules with sulfation activity are probably identical. First, Hall [9] used almost the same purification procedure as was used by our group [3, 6] to purify NSILA-S. The physicoehemical similarities between the sulfation factor and NSILA-S are further stressed in a recent publication of Uthne [16] . NSILA to sulfation activity remained similar during a 6 500-fold purification of sulfation activity and the thymidine factor could not be removed by this preparative procedure [9, 10] . Second, the ratio of NSILA-S to sulfation activity was similar in 3 preparations of NSILA-S with 0.8, 17 and 61 mU/mg, respectively. Partially purified preparations of sulfation factor and serum of acromegalic patients have been shown to exert the following effects, common to insulin and, in part, also to NSILA-S. Serum fractions with sulfation activity stimulate amino acid incorporation into muscle and cartilage [17] , leucine and sulfate incorporation into proteinpolysaccharide complexes, uridine incorporation into I~NA as well as thymidine incorporation into DNA of cartilage of hypophyseetomized rats and of chicken embryo fibroblasts [7, 8, 12, 14, 18, 19] . They also promote He-La cell growth [20] . Furthermore, they also exert an antilipolytic effect [21] . Because of its growth promoting effect, the sulfation factor has lately been baptized "Somatomedin" [22] . In recent experiments in our laboratories both activities were found in the same serum fractions. In these same fractions both activities were found to be decreased in pituitary dwarfs and increased in aeromegalies (Schlumpf, in preparation).
There appears to be some disagreement as to the ratio of NSILA-S to sulfation activity. Hall [9, 10] claims that 1 sulfation unit defined as sulfation activity per ml of normal serum corresponds to about 200 ~U of NSILA. According to Jakob et al. [2] only 10--20% of total serum ILA (200 ~zU/ml) corresponds to NSILA-S.
Therefore, we would assume that 1 sulfation unit should be equivalent to approximately 10 to 20 ~zU of NSILA-S. In fact, we have found that 10~o serum of a normal subjects exerts approximately the same effect as 2 vU of purified NSILA-S. However, in view of the different slopes obtained with serum on one hand and purified NSILA-S on the other hand, quantitative estimates based on curves obtained with serum appear hardly justified. It is also interesting that Hall [9] found the same ratio of NSILA to sulfation activity before and after acid-alcohol extraction of serum, a procedure by which NSILA-P is removed. We have tested several partially purified preparations of NSILA-P in the sulfation assay (200 ~U/mg) and have found them to be inactive in low and even inhibitory in higher concentrations. Our preparation of NSILA-S with 0.8 mU/mg was also inhibitory at 1000 ~zU/ml. Whether or not these inhibitory effects are due to artefacts produced during the purification procedure is unknown. However, these complications will make it difficult to accurately assess the quantitative relationship in serum and serum fractions between NSILA-S and sulfation factor. For this purpose, radioimmunoassays would be of great help. So far, we have been unsuccessful in immunizing guinea pigs and rabbits against NSILA-S and, as far as we know, an immunoassay for sulfation factor does not yet exist.
